Intact noradrenaline transporter is needed for the sympathetic fine-tuning of cytokine balance

Zsolt Selmeczy, J. Szelényi, E. Vízi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Earlier studies demonstrated that cytokine production is under the tonic control of noradrenaline. As the level and/or the duration of noradrenaline action is regulated by the noradrenaline transporter (NET), which is also a target of antidepressant treatment, we studied its role in the regulation of the cytokine response during inflammation. The endotoxin-evoked tumour necrosis factor-alpha (TNF-α) and interleukin-10 response was studied in genetically produced noradrenaline transporter-deficient (NET-KO) mice and by treatment with desipramine, a monoamine uptake-blocker antidepressant. NET-KO mice responded to endotoxin with significantly lower TNF-α and interleukin-10 production in comparison to their wild-type counterparts. Functional involvement of both α- and β-adrenoceptors could be demonstrated in our model systems, using 7,8-methylenedioxy-14α-hydroxy-alloberbane·HCl (CH-38083) and propranolol; however, the differences between the two phenotypes remained, suggesting a limited role of α-adrenoceptors in the observed changes. Acute treatment of both wild-type and NET-KO mice with desipramine significantly decreased the TNF-α response and significantly increased interleukin-10 production, indicating the role of an intact noradrenaline transporter in anti-inflammatory responses.

Original languageEnglish
Pages (from-to)175-181
Number of pages7
JournalEuropean Journal of Pharmacology
Volume469
Issue number1-3
DOIs
Publication statusPublished - May 23 2003

Fingerprint

Norepinephrine Plasma Membrane Transport Proteins
Cytokines
Interleukin-10
Desipramine
Tumor Necrosis Factor-alpha
Endotoxins
Adrenergic Receptors
Antidepressive Agents
Norepinephrine
Propranolol
Anti-Inflammatory Agents
Inflammation
Phenotype

Keywords

  • Antidepressants
  • Cytokine production
  • Mouse
  • NET-KO
  • Noradrenaline uptake

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Intact noradrenaline transporter is needed for the sympathetic fine-tuning of cytokine balance. / Selmeczy, Zsolt; Szelényi, J.; Vízi, E.

In: European Journal of Pharmacology, Vol. 469, No. 1-3, 23.05.2003, p. 175-181.

Research output: Contribution to journalArticle

@article{ca2e704e67094d1db3d8fb01b590f871,
title = "Intact noradrenaline transporter is needed for the sympathetic fine-tuning of cytokine balance",
abstract = "Earlier studies demonstrated that cytokine production is under the tonic control of noradrenaline. As the level and/or the duration of noradrenaline action is regulated by the noradrenaline transporter (NET), which is also a target of antidepressant treatment, we studied its role in the regulation of the cytokine response during inflammation. The endotoxin-evoked tumour necrosis factor-alpha (TNF-α) and interleukin-10 response was studied in genetically produced noradrenaline transporter-deficient (NET-KO) mice and by treatment with desipramine, a monoamine uptake-blocker antidepressant. NET-KO mice responded to endotoxin with significantly lower TNF-α and interleukin-10 production in comparison to their wild-type counterparts. Functional involvement of both α- and β-adrenoceptors could be demonstrated in our model systems, using 7,8-methylenedioxy-14α-hydroxy-alloberbane·HCl (CH-38083) and propranolol; however, the differences between the two phenotypes remained, suggesting a limited role of α-adrenoceptors in the observed changes. Acute treatment of both wild-type and NET-KO mice with desipramine significantly decreased the TNF-α response and significantly increased interleukin-10 production, indicating the role of an intact noradrenaline transporter in anti-inflammatory responses.",
keywords = "Antidepressants, Cytokine production, Mouse, NET-KO, Noradrenaline uptake",
author = "Zsolt Selmeczy and J. Szel{\'e}nyi and E. V{\'i}zi",
year = "2003",
month = "5",
day = "23",
doi = "10.1016/S0014-2999(03)01721-7",
language = "English",
volume = "469",
pages = "175--181",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Intact noradrenaline transporter is needed for the sympathetic fine-tuning of cytokine balance

AU - Selmeczy, Zsolt

AU - Szelényi, J.

AU - Vízi, E.

PY - 2003/5/23

Y1 - 2003/5/23

N2 - Earlier studies demonstrated that cytokine production is under the tonic control of noradrenaline. As the level and/or the duration of noradrenaline action is regulated by the noradrenaline transporter (NET), which is also a target of antidepressant treatment, we studied its role in the regulation of the cytokine response during inflammation. The endotoxin-evoked tumour necrosis factor-alpha (TNF-α) and interleukin-10 response was studied in genetically produced noradrenaline transporter-deficient (NET-KO) mice and by treatment with desipramine, a monoamine uptake-blocker antidepressant. NET-KO mice responded to endotoxin with significantly lower TNF-α and interleukin-10 production in comparison to their wild-type counterparts. Functional involvement of both α- and β-adrenoceptors could be demonstrated in our model systems, using 7,8-methylenedioxy-14α-hydroxy-alloberbane·HCl (CH-38083) and propranolol; however, the differences between the two phenotypes remained, suggesting a limited role of α-adrenoceptors in the observed changes. Acute treatment of both wild-type and NET-KO mice with desipramine significantly decreased the TNF-α response and significantly increased interleukin-10 production, indicating the role of an intact noradrenaline transporter in anti-inflammatory responses.

AB - Earlier studies demonstrated that cytokine production is under the tonic control of noradrenaline. As the level and/or the duration of noradrenaline action is regulated by the noradrenaline transporter (NET), which is also a target of antidepressant treatment, we studied its role in the regulation of the cytokine response during inflammation. The endotoxin-evoked tumour necrosis factor-alpha (TNF-α) and interleukin-10 response was studied in genetically produced noradrenaline transporter-deficient (NET-KO) mice and by treatment with desipramine, a monoamine uptake-blocker antidepressant. NET-KO mice responded to endotoxin with significantly lower TNF-α and interleukin-10 production in comparison to their wild-type counterparts. Functional involvement of both α- and β-adrenoceptors could be demonstrated in our model systems, using 7,8-methylenedioxy-14α-hydroxy-alloberbane·HCl (CH-38083) and propranolol; however, the differences between the two phenotypes remained, suggesting a limited role of α-adrenoceptors in the observed changes. Acute treatment of both wild-type and NET-KO mice with desipramine significantly decreased the TNF-α response and significantly increased interleukin-10 production, indicating the role of an intact noradrenaline transporter in anti-inflammatory responses.

KW - Antidepressants

KW - Cytokine production

KW - Mouse

KW - NET-KO

KW - Noradrenaline uptake

UR - http://www.scopus.com/inward/record.url?scp=0038730503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038730503&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(03)01721-7

DO - 10.1016/S0014-2999(03)01721-7

M3 - Article

C2 - 12782200

AN - SCOPUS:0038730503

VL - 469

SP - 175

EP - 181

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -